These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 20132973

  • 1. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E, Escamochero S, Cabañas R, Díaz R, Fiandor A, Bellón T.
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [Abstract] [Full Text] [Related]

  • 2. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M, Busch LK, Salazar-Fontana LI, Bellosillo B, Morte C, García P, López-Botet M.
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [Abstract] [Full Text] [Related]

  • 3. Expression of NK cell receptors on decidual T cells in human pregnancy.
    Tilburgs T, van der Mast BJ, Nagtzaam NM, Roelen DL, Scherjon SA, Claas FH.
    J Reprod Immunol; 2009 Jun; 80(1-2):22-32. PubMed ID: 19394706
    [Abstract] [Full Text] [Related]

  • 4. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M, Yamashita T, Fujii T, Nagamatsu T, Kozuma S, Taketani Y.
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [Abstract] [Full Text] [Related]

  • 5. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H, Matsumoto N, Maenaka K, Suzuki K, Yamamoto K.
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [Abstract] [Full Text] [Related]

  • 6. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ.
    Nature; 1998 Feb 19; 391(6669):795-9. PubMed ID: 9486650
    [Abstract] [Full Text] [Related]

  • 7. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P, Santoni A.
    Fertil Steril; 2008 May 19; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [Abstract] [Full Text] [Related]

  • 8. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J, Park JS, Nam JH, Bang D, Sohn S, Lee ES, Park KS.
    Tissue Antigens; 2007 Oct 19; 70(4):307-13. PubMed ID: 17767552
    [Abstract] [Full Text] [Related]

  • 9. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.
    Eur J Immunol; 2003 Jun 19; 33(6):1657-66. PubMed ID: 12778484
    [Abstract] [Full Text] [Related]

  • 10. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H, Wauquier N, Cherfils-Vicini J, Cremer I, Debré P, Vieillard V.
    AIDS; 2008 Jan 11; 22(2):217-26. PubMed ID: 18097224
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L.
    Eur J Immunol; 1997 Jun 11; 27(6):1374-80. PubMed ID: 9209487
    [Abstract] [Full Text] [Related]

  • 12. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ, Melero I, Navarro F, Carretero M, Bellón T, Llano M, Colonna M, Geraghty DE, López-Botet M.
    J Immunol; 1997 Jun 15; 158(12):5736-43. PubMed ID: 9190923
    [Abstract] [Full Text] [Related]

  • 13. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
    Chung WH, Hung SI.
    Allergol Int; 2010 Dec 15; 59(4):325-32. PubMed ID: 20962567
    [Abstract] [Full Text] [Related]

  • 14. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT.
    Nat Med; 2008 Dec 15; 14(12):1343-50. PubMed ID: 19029983
    [Abstract] [Full Text] [Related]

  • 15. NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease.
    Angelini DF, Zambello R, Galandrini R, Diamantini A, Placido R, Micucci F, Poccia F, Semenzato G, Borsellino G, Santoni A, Battistini L.
    J Leukoc Biol; 2011 Jan 15; 89(1):75-84. PubMed ID: 20952657
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cells.
    Enqvist M, Nilsonne G, Hammarfjord O, Wallin RP, Björkström NK, Björnstedt M, Hjerpe A, Ljunggren HG, Dobra K, Malmberg KJ, Carlsten M.
    J Immunol; 2011 Oct 01; 187(7):3546-54. PubMed ID: 21890659
    [Abstract] [Full Text] [Related]

  • 18. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM.
    Eur J Immunol; 2000 Jun 01; 30(6):1623-31. PubMed ID: 10898498
    [Abstract] [Full Text] [Related]

  • 19. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A.
    Eur J Immunol; 1997 Aug 01; 27(8):1875-80. PubMed ID: 9295021
    [Abstract] [Full Text] [Related]

  • 20. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.
    Nattermann J, Nischalke HD, Hofmeister V, Ahlenstiel G, Zimmermann H, Leifeld L, Weiss EH, Sauerbruch T, Spengler U.
    Am J Pathol; 2005 Feb 01; 166(2):443-53. PubMed ID: 15681828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.